Recombinant Bovine Somatotropin vs Olestra: which is worse?

What is Recombinant Bovine Somatotropin?

Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.

What is Olestra?

Olestra (brand name Olean) is a synthetic fat substitute made from sucrose and fatty acids. Unlike regular fats, olestra is not absorbed by the digestive system — it passes through the body unchanged, providing zero calories while mimicking fat's texture and taste in food. It was developed by Procter & Gamble and FDA-approved in 1996.

Documented risks

Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.

Olestra: Olestra caused significant gastrointestinal side effects that were prominently noted on mandatory warning labels: 'This Product Contains Olestra. Olestra may cause abdominal cramping and loose stools. Olestra inhibits the absorption of some vitamins and other nutrients. Vitamins A, D, E, and K have been added.' Reported gastrointestinal effects included diarrhea, abdominal cramping, oily anal leakage ('anal leakage' or 'rectal leakage'), and fatty stools. These effects were often embarrassing and uncomfortable. Multiple consumer complaints documented GI distress from Olean chips. Beyond GI effects, olestra significantly inhibits the absorption of fat-soluble vitamins (A, D, E, K) and fat-soluble carotenoids (lycopene, lutein, beta-carotene). Since fat-soluble vitamins require fat for absorption, and olestra passes through without being absorbed, it 'captures' these vitamins and carries them out of the body. Studies found olestra consumption reduced serum carotenoid levels, prompting Frito-Lay to fortify olestra products with fat-soluble vitamins to compensate. The FDA removed the mandatory GI warning requirement in 2003 after Frito-Lay argued the warning was overstated, though olestra's use had already declined dramatically due to consumer avoidance.